Logo Logo
Loading...
CreatedOn: 15 May, 2024
LastUpdatedOn: 30 May, 2024

Colon Cancer

What About Colorectal Cancer?

Colorectal cancer was ranked first among Saudi males and third among Saudi females. There were 1729 cases of colorectal cancer accounting for 12.3% of all newly diagnosed cases in the year 2020 among Saudi nationals. It affected 966 (55.9%) males and 763 (44.1%) females with a male to female ratio of 126 to 100. 

              The age-Standardized Incidence Rate (ASR) was 12.4/100,000 for males and 9.6/100,000 for females. The five regions with the highest ASR in males were Riyadh at 18.3/100,000 Eastern region at 16.1/100,000, followed by Qassim at 11.7/100,000, then Tabuk at 11.4/100,000, and Makkah at 11.3/100,000. 

              In females, regions with the highest ASR were Riyadh at 16.5/100,000, followed by Qassim at 12.5/100,000, then Eastern region at 12.1/100,000, then Makkah at 9.2/100,000, and Jouf at 9/100,000 (Figure 3.2.3). The median age at diagnosis was 60 years in males (ranging between 17 and 98) and 58 years in females (ranging between 20 and 98).

Aim of the pathway: 
  • Early detection and decrease mortality of breast cancer
Desired outcome of the pathway:

1- Raising the rates of diagnosis and early detection cancer at an early stage of the disease.

2- Reduce incidence of breast cancer mortality.

Assessment

Early and Periodic Screening for Colorectal Cancer: 

 The severity of colorectal cancer can vary based on the following factors:

1.   Fecal Immunohistochemical Test (FIT):

o   Target group: people at moderate risk of the disease (aged 45 - 75 years).

o   Result:

§  Negative: The FIT is repeated once a year.

§  Positive: The patient is referred to total colonoscopy. 

2.   Total colonoscopy:

o   Target group:

§  People at high risk of the disease.

§  People with a positive FOBT result.

o   Result:

§  Negative: The colonoscopy is repeated:

§  Once every 5 years for people at moderate risk of the disease.

§  Once a year for people at high risk of the disease.

§  Positive: The patient is referred to therapy.

Screening criteria:

The target population are categorized depending on their risk:

Average Risk Group: 

Age (45 - 75). 

-        No family history of CRC or personal history of polyps.

High Risk Group: 

• Family history of CRC.

- One first-degree relatives with CRC.

- Two or more second-degree relatives with CRC.

• Personal history of adenomatous polyp or inflammatory bowel disease.

• Genetic syndrome predisposing to CRC (HNPCC, FAP).

• Personal history of childhood cancer requiring abdominal radiation.

Management

Management

Treatment options depend on the following:

1.   Type of tumor.

2.   Place of tumor.

3.   Stage and spread of tumor.

4.   General condition of the patient.

5.   Having other diseases.

Methods of treatment:

1.   Surgical treatment.

2.   Chemotherapy.

3.   Radiation therapy.

4.   Immunotherapy.

Prevention:
Methods to prevent the colorectal cancer:

  • Quit Smoking.
  • Avoid obesity and maintain normal weight.
  • Reduce fat, especially saturated fats.
  • Eat fruits, vegetables and healthy food rich in fiber.
  • Exercise regularly.

Referral: refer to different specialist services if needed: oncologist, nutritionists and dietitians, occupational therapist, psychologist, psychiatrists, and social workers.

 

Request

Request

Request FIT

 Request further evaluation if positive FIT: Total colonoscopy

 

Information